Compare Neurocrine Biosciences Inc (NBIX) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Upstart Holdings Inc — how do they compare? Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B), while Upstart Holdings Inc trades at $29.93 (market cap $2.91B). The key difference: Neurocrine Biosciences Inc is far larger — about 5.7× Upstart Holdings Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Upstart Holdings Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | UPST | |
|---|---|---|
Market Cap | $16.46B | $2.91B |
Sector | Health | Financials |
52-Week High | $185.50 | $73.76 |
52-Week Low | $123.10 | $24.22 |
Enterprise Value | $16.48B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
